Acceptability and Accessibility of a Shigellosis Vaccine in Nha Trang City of Viet Nam‪.‬

INTRODUCTION While several candidate Shigella vaccines are at various stages of clinical testing, there is currently no viable vaccine available for introduction into a public-health programme. As vaccine development continues, there is also a need to understand the population demand for such a vaccine in those countries where a future vaccine would most likely be used. The Diseases of the Most Impoverished (DOMI) Programme of the International Vaccine Institute, Seoul, Korea, has implemented shigellosis disease-burden studies in Bangladesh, China, Indonesia, Pakistan, Thailand, and Viet Nam. As part of these projects, sociobehavioural research has been conducted to obtain data on perceptions and attitudes of healthcare providers, community leaders, and community residents towards shigellosis and other diarrhoeal diseases, healthcare use relating to diarrhoeal diseases, experience and attitudes towards vaccination, and logistical factors relating to delivery of vaccine.